Press Releases

  • Webcast
    Lantheus at Jefferies 2017 Global Healthcare Conference (Replay)
    Tuesday, Jun 6, 2017 at 9:30 AM EDT
Date Title
05/23/17
Summary ToggleLantheus Holdings, Inc. to Present at Jefferies 2017 Global Healthcare Conference Summary ToggleLantheus Holdings, Inc. to Present at Jefferies 2017 Global Healthcare Conference
NORTH BILLERICA, Mass. --(BUSINESS WIRE)--May 23, 2017-- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI”), today announced it will be presenting at the Jefferies 2017 Global Healthcare Conference on Tuesday, June 6 in New York .
05/03/17
Summary ToggleLantheus Holdings, Inc. Announces Public Secondary Offering by Selling Stockholders of 3,000,000 Shares of Common Stock Summary ToggleLantheus Holdings, Inc. Announces Public Secondary Offering by Selling Stockholders of 3,000,000 Shares of Common Stock
NORTH BILLERICA, Mass. --(BUSINESS WIRE)--May 3, 2017-- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ:LNTH), today announced an agreement to sell 3,000,000 shares of its common stock to be offered by certain of its existing stockholders (the “Selling Stockholders”), pursuant to an
05/02/17
Summary ToggleLantheus Holdings, Inc. Reports 2017 First Quarter Financial Results; Exceeds First Quarter and Raises Full-Year 2017 Guidance Summary ToggleLantheus Holdings, Inc. Reports 2017 First Quarter Financial Results; Exceeds First Quarter and Raises Full-Year 2017 Guidance
Posts Q1 revenue of $81.4 million , net income of $4.1 million and Adjusted EBITDA of $22.7 million DEFINITY ® worldwide revenue increases 20% over prior year period Completion of debt refinancing enhances capital structure NORTH BILLERICA, Mass. --(BUSINESS WIRE)--May 2, 2017-- Lantheus Holdings,
04/25/17
Summary ToggleLantheus and GE Healthcare Announce the Signing of a Definitive License Agreement for Worldwide Development and Commercialization of Flurpiridaz F 18 Summary ToggleLantheus and GE Healthcare Announce the Signing of a Definitive License Agreement for Worldwide Development and Commercialization of Flurpiridaz F 18
Companies also announce the extension and expansion of their existing commercial supply agreement for nuclear products through 2020 NORTH BILLERICA, Mass. --(BUSINESS WIRE)--Apr. 25, 2017-- Lantheus Holdings, Inc . (NASDAQ: LNTH), parent company of Lantheus Medical Imaging, Inc.
04/18/17
Summary ToggleLantheus Holdings to Host First Quarter 2017 Earnings Conference Call on May 2, 2017 at 4:30 p.m. Eastern Time Summary ToggleLantheus Holdings to Host First Quarter 2017 Earnings Conference Call on May 2, 2017 at 4:30 p.m. Eastern Time
NORTH BILLERICA, Mass. --(BUSINESS WIRE)--Apr. 18, 2017-- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call at 4:30 p.m. ET on Tuesday, May 2, 2017 , to discuss its financial and operating results for the first quarter of 2017.
03/30/17
Summary ToggleLantheus Announces Refinancing of its Debt Facility Summary ToggleLantheus Announces Refinancing of its Debt Facility
Increases available liquidity; positive impact on cash flow projected to be approximately $5 million per year NORTH BILLERICA, Mass. --(BUSINESS WIRE)--Mar. 30, 2017-- Lantheus Holdings, Inc. (NASDAQ: LNTH), parent company of Lantheus Medical Imaging, Inc.
03/13/17
Summary ToggleLantheus Holdings, Inc. Announces Public Secondary Offering of 3,000,000 Shares of Common Stock by Selling Stockholders Summary ToggleLantheus Holdings, Inc. Announces Public Secondary Offering of 3,000,000 Shares of Common Stock by Selling Stockholders
02/21/17
Summary ToggleLantheus Holdings, Inc. Reports 2016 Fourth Quarter and Full Year Financial Results; Provides 2017 Guidance Summary ToggleLantheus Holdings, Inc. Reports 2016 Fourth Quarter and Full Year Financial Results; Provides 2017 Guidance
02/21/17
Summary ToggleLantheus Holdings and GE Healthcare Announce the Signing of a Term Sheet for Worldwide Development and Commercialization of Flurpiridaz F 18 Summary ToggleLantheus Holdings and GE Healthcare Announce the Signing of a Term Sheet for Worldwide Development and Commercialization of Flurpiridaz F 18
02/07/17
Summary ToggleLantheus Holdings to Host Fourth Quarter and Full Year 2016 Earnings Conference Call and Provide 2017 Guidance on February 21, 2017 at 4:30 p.m. Eastern Time Summary ToggleLantheus Holdings to Host Fourth Quarter and Full Year 2016 Earnings Conference Call and Provide 2017 Guidance on February 21, 2017 at 4:30 p.m. Eastern Time
02/02/17
Summary ToggleLantheus Medical Imaging Announces FDA Approval of DEFINITY® Label Update Summary ToggleLantheus Medical Imaging Announces FDA Approval of DEFINITY® Label Update
01/26/17
Summary ToggleLantheus Holdings Appoints New Member to its Board of Directors Summary ToggleLantheus Holdings Appoints New Member to its Board of Directors
11/15/16
Summary ToggleLantheus Holdings, Inc. Announces Upsize of Public Offering to 3,500,000 Shares of Common Stock Summary ToggleLantheus Holdings, Inc. Announces Upsize of Public Offering to 3,500,000 Shares of Common Stock
11/15/16
Summary ToggleLantheus Holdings, Inc. Announces Public Offering of 3,000,000 Shares of Common Stock Summary ToggleLantheus Holdings, Inc. Announces Public Offering of 3,000,000 Shares of Common Stock
11/01/16
Summary ToggleLantheus Holdings, Inc. Reports 2016 Third Quarter Financial Results Summary ToggleLantheus Holdings, Inc. Reports 2016 Third Quarter Financial Results
10/24/16
Summary ToggleLantheus Holdings to Present at 25th Annual Credit Suisse Healthcare Conference Summary ToggleLantheus Holdings to Present at 25th Annual Credit Suisse Healthcare Conference
10/18/16
Summary ToggleLantheus Holdings to Host Third Quarter 2016 Earnings Conference Call on November 1, 2016 at 4:30 p.m. Eastern Time Summary ToggleLantheus Holdings to Host Third Quarter 2016 Earnings Conference Call on November 1, 2016 at 4:30 p.m. Eastern Time
09/22/16
Summary ToggleLantheus to Present New Data at the ASNC Annual Scientific Session on the Novel PET Cardiac Imaging Agent Flurpiridaz F 18 in Patients with Suspected Heart Disease Undergoing Exercise Stress Testing Summary ToggleLantheus to Present New Data at the ASNC Annual Scientific Session on the Novel PET Cardiac Imaging Agent Flurpiridaz F 18 in Patients with Suspected Heart Disease Undergoing Exercise Stress Testing
09/08/16
Summary ToggleLantheus Holdings, Inc. Announces Public Offering of 5,200,000 Shares of Common Stock Summary ToggleLantheus Holdings, Inc. Announces Public Offering of 5,200,000 Shares of Common Stock
08/24/16
Summary ToggleLantheus Holdings, Inc. to Present at Upcoming Investor Conferences Summary ToggleLantheus Holdings, Inc. to Present at Upcoming Investor Conferences
08/11/16
Summary ToggleLantheus Holdings Announces Divestiture of Its Australian Radiopharmacy Servicing Business and Entry into Long-Term Supply and Distribution Agreement Summary ToggleLantheus Holdings Announces Divestiture of Its Australian Radiopharmacy Servicing Business and Entry into Long-Term Supply and Distribution Agreement
08/04/16
Summary ToggleLantheus Holdings, Inc. Reports 2016 Second Quarter Financial Results Summary ToggleLantheus Holdings, Inc. Reports 2016 Second Quarter Financial Results
07/21/16
Summary ToggleLantheus Holdings to Host Second Quarter 2016 Earnings Conference Call on August 4, 2016 at 4:30 p.m. Eastern Time Summary ToggleLantheus Holdings to Host Second Quarter 2016 Earnings Conference Call on August 4, 2016 at 4:30 p.m. Eastern Time
06/30/16
Summary ToggleLantheus Holdings Announces First Commercial Shipment of Xenon 133 Supplied by Institute for Radioelements (IRE) Summary ToggleLantheus Holdings Announces First Commercial Shipment of Xenon 133 Supplied by Institute for Radioelements (IRE)
05/19/16
Summary ToggleLantheus Holdings, Inc. to Present at Jefferies 2016 Healthcare Conference Summary ToggleLantheus Holdings, Inc. to Present at Jefferies 2016 Healthcare Conference
05/03/16
Summary ToggleLantheus Holdings, Inc. Reports 2016 First Quarter Financial Results Summary ToggleLantheus Holdings, Inc. Reports 2016 First Quarter Financial Results
04/19/16
Summary ToggleLantheus Holdings to Host First Quarter 2016 Earnings Conference Call on May 3, 2016 at 4:30 p.m. Eastern Time Summary ToggleLantheus Holdings to Host First Quarter 2016 Earnings Conference Call on May 3, 2016 at 4:30 p.m. Eastern Time
04/04/16
Summary ToggleLantheus Presents New Data on the Effectiveness of Novel PET Cardiac Imaging Agent Flurpiridaz F 18 in Obese Patients with Suspected Heart Disease at ACC Scientific Session Summary ToggleLantheus Presents New Data on the Effectiveness of Novel PET Cardiac Imaging Agent Flurpiridaz F 18 in Obese Patients with Suspected Heart Disease at ACC Scientific Session
03/28/16
Summary ToggleLantheus Holdings Announces Appointment of Jack Crowley as Chief Financial Officer Summary ToggleLantheus Holdings Announces Appointment of Jack Crowley as Chief Financial Officer
03/08/16
Summary ToggleLantheus Holdings Announces Retirement of Director Dr. Patrick O’Neill; Appoints Two New Board Members Summary ToggleLantheus Holdings Announces Retirement of Director Dr. Patrick O’Neill; Appoints Two New Board Members
02/22/16
Summary ToggleLantheus Holdings, Inc. Reports 2015 Fourth Quarter and Full Year Financial Results; Provides 2016 Guidance Summary ToggleLantheus Holdings, Inc. Reports 2015 Fourth Quarter and Full Year Financial Results; Provides 2016 Guidance
02/09/16
Summary ToggleLantheus Holdings, Inc. to Participate in the 2016 RBC Capital Markets’ Global Healthcare Conference Summary ToggleLantheus Holdings, Inc. to Participate in the 2016 RBC Capital Markets’ Global Healthcare Conference
02/08/16
Summary ToggleLantheus Holdings to Host Fourth Quarter and Full Year 2015 Earnings Conference Call and Provide 2016 Guidance on February 22, 2016 at 4:30 p.m. Eastern Time Summary ToggleLantheus Holdings to Host Fourth Quarter and Full Year 2015 Earnings Conference Call and Provide 2016 Guidance on February 22, 2016 at 4:30 p.m. Eastern Time
01/13/16
Summary ToggleLantheus Holdings Announces Divestiture of Its Canadian Radiopharmacy Operations and Commencement of Long-Term Supply Agreement Summary ToggleLantheus Holdings Announces Divestiture of Its Canadian Radiopharmacy Operations and Commencement of Long-Term Supply Agreement
12/10/15
Summary ToggleLantheus Holdings Announces Appointment of Jack Crowley as Interim Chief Financial Officer Summary ToggleLantheus Holdings Announces Appointment of Jack Crowley as Interim Chief Financial Officer
11/08/15
Summary ToggleLantheus Presents New Data on the Effectiveness of Novel PET Cardiac Imaging Agent Flurpiridaz F 18 in Women with Suspected Heart Disease at AHA Scientific Sessions 2015 Summary ToggleLantheus Presents New Data on the Effectiveness of Novel PET Cardiac Imaging Agent Flurpiridaz F 18 in Women with Suspected Heart Disease at AHA Scientific Sessions 2015
11/04/15
Summary ToggleLantheus Holdings, Inc. Reports 2015 Third Quarter Financial Results Summary ToggleLantheus Holdings, Inc. Reports 2015 Third Quarter Financial Results
11/02/15
Summary ToggleLantheus to Present New Data on the Effectiveness of Novel PET Cardiac Imaging Agent Flurpiridaz F 18 in Women with Suspected Heart Disease at the American Heart Association 2015 Scientific Sessions Summary ToggleLantheus to Present New Data on the Effectiveness of Novel PET Cardiac Imaging Agent Flurpiridaz F 18 in Women with Suspected Heart Disease at the American Heart Association 2015 Scientific Sessions
10/30/15
Summary ToggleLantheus Holdings, Inc. to Present at 24th Annual Credit Suisse Healthcare Conference Summary ToggleLantheus Holdings, Inc. to Present at 24th Annual Credit Suisse Healthcare Conference
10/21/15
Summary ToggleLantheus Holdings to Host Third Quarter 2015 Earnings Conference Call on November 4, 2015 at 4:30 P.M. Eastern Time Summary ToggleLantheus Holdings to Host Third Quarter 2015 Earnings Conference Call on November 4, 2015 at 4:30 P.M. Eastern Time
08/31/15
Summary ToggleLantheus Holdings, Inc. to Present at Upcoming Investor Conferences Summary ToggleLantheus Holdings, Inc. to Present at Upcoming Investor Conferences
08/28/15
Summary ToggleLantheus Holdings Announces Appointment of Mary Anne Heino as President and Chief Executive Officer Summary ToggleLantheus Holdings Announces Appointment of Mary Anne Heino as President and Chief Executive Officer
08/04/15
Summary ToggleLantheus Holdings, Inc. Reports 2015 Second Quarter Financial Results Summary ToggleLantheus Holdings, Inc. Reports 2015 Second Quarter Financial Results
07/21/15
Summary ToggleLantheus Holdings to Host Second Quarter 2015 Earnings Conference Call on August 4, 2015 at 4:30 p.m. Eastern Time Summary ToggleLantheus Holdings to Host Second Quarter 2015 Earnings Conference Call on August 4, 2015 at 4:30 p.m. Eastern Time
07/09/15
Summary ToggleLantheus Holdings Appoints New Member to its Board of Directors Summary ToggleLantheus Holdings Appoints New Member to its Board of Directors
06/30/15
Summary ToggleLantheus Announces Closing of Initial Public Offering and Debt Refinancing Summary ToggleLantheus Announces Closing of Initial Public Offering and Debt Refinancing
06/24/15
Summary ToggleLantheus Holdings, Inc. Prices its Initial Public Offering Summary ToggleLantheus Holdings, Inc. Prices its Initial Public Offering
05/05/15
Summary ToggleLantheus Medical Imaging Reports 2015 First Quarter Financial Results Summary ToggleLantheus Medical Imaging Reports 2015 First Quarter Financial Results
05/04/15
Summary ToggleResults from Lantheus Medical Imaging’s First Phase 3 Study of Novel PET Cardiac Imaging Agent Flurpiridaz F 18 Presented at ICNC12 Summary ToggleResults from Lantheus Medical Imaging’s First Phase 3 Study of Novel PET Cardiac Imaging Agent Flurpiridaz F 18 Presented at ICNC12
04/21/15
Summary ToggleLantheus to Host First Quarter 2015 Earnings Conference Call on May 5, 2015 at 4:30 p.m. Eastern Time Summary ToggleLantheus to Host First Quarter 2015 Earnings Conference Call on May 5, 2015 at 4:30 p.m. Eastern Time
03/16/15
Summary ToggleLantheus Medical Imaging Promotes Mary Anne Heino To Chief Operating Officer Summary ToggleLantheus Medical Imaging Promotes Mary Anne Heino To Chief Operating Officer
03/04/15
Summary ToggleLantheus Medical Imaging Reports 2014 Fourth Quarter and Full Year Financial Results Summary ToggleLantheus Medical Imaging Reports 2014 Fourth Quarter and Full Year Financial Results
02/25/15
Summary ToggleLantheus to Host Fourth Quarter and Full Year 2014 Earnings Conference Call on March 4, 2015 at 4:30 p.m. Eastern Time Summary ToggleLantheus to Host Fourth Quarter and Full Year 2014 Earnings Conference Call on March 4, 2015 at 4:30 p.m. Eastern Time
01/29/15
Summary ToggleLantheus Medical Imaging Announces FDA Approval of Jubilant HollisterStier as a New Manufacturing Site for NEUROLITE® Summary ToggleLantheus Medical Imaging Announces FDA Approval of Jubilant HollisterStier as a New Manufacturing Site for NEUROLITE®
01/21/15
Summary ToggleLantheus Medical Imaging Announces Xenon 133 Supply Agreement with Institute for Radioelements Summary ToggleLantheus Medical Imaging Announces Xenon 133 Supply Agreement with Institute for Radioelements
11/12/14
Summary ToggleLantheus Medical Imaging Reports Third Quarter 2014 Financial Results Summary ToggleLantheus Medical Imaging Reports Third Quarter 2014 Financial Results
11/05/14
Summary ToggleLantheus to Host Third Quarter 2014 Earnings Conference Call on November 12, 2014 at 4:30 p.m. Eastern Time Summary ToggleLantheus to Host Third Quarter 2014 Earnings Conference Call on November 12, 2014 at 4:30 p.m. Eastern Time
11/03/14
Summary ToggleLantheus Medical Imaging and SHINE Medical Announce Mo-99 Supply Agreement Summary ToggleLantheus Medical Imaging and SHINE Medical Announce Mo-99 Supply Agreement
09/18/14
Summary ToggleLantheus Medical Imaging to Present Data on Novel PET Cardiac Imaging Agent Flurpiridaz F 18 at ASNC Annual Scientific Session Summary ToggleLantheus Medical Imaging to Present Data on Novel PET Cardiac Imaging Agent Flurpiridaz F 18 at ASNC Annual Scientific Session
09/10/14
Summary ToggleLantheus Medical Imaging to Present at Imperial Capital Global Opportunities Conference on September 18, 2014 Summary ToggleLantheus Medical Imaging to Present at Imperial Capital Global Opportunities Conference on September 18, 2014
08/12/14
Summary ToggleLantheus Medical Imaging Reports Results for Second Quarter Ended June 30, 2014 Summary ToggleLantheus Medical Imaging Reports Results for Second Quarter Ended June 30, 2014
08/05/14
Summary ToggleLantheus to Host Second Quarter 2014 Conference Call on August 12, 2014 at 4:30 p.m. Eastern Time Summary ToggleLantheus to Host Second Quarter 2014 Conference Call on August 12, 2014 at 4:30 p.m. Eastern Time
06/24/14
Summary ToggleLantheus Holdings, Inc. Announces Filing of Registration Statement for Proposed Initial Public Offering Summary ToggleLantheus Holdings, Inc. Announces Filing of Registration Statement for Proposed Initial Public Offering
06/02/14
Summary ToggleLantheus Medical Imaging Announces appointment of John K. Bakewell as New Chief financial Officer Summary ToggleLantheus Medical Imaging Announces appointment of John K. Bakewell as New Chief financial Officer
05/01/14
Summary ToggleLantheus to Host First Quarter 2014 Conference Call on May 6, 2014 at 3:00 p.m. Eastern Time Summary ToggleLantheus to Host First Quarter 2014 Conference Call on May 6, 2014 at 3:00 p.m. Eastern Time
03/10/14
Summary ToggleLantheus to Host Fourth Quarter and Full Year 2013 Conference Call on March 12, 2014 at 3:00 p.m. Eastern Time Summary ToggleLantheus to Host Fourth Quarter and Full Year 2013 Conference Call on March 12, 2014 at 3:00 p.m. Eastern Time
02/20/14
Summary ToggleLantheus Medical Imaging to Present at the RBC Capital Healthcare Conference on February 26, 2014 Summary ToggleLantheus Medical Imaging to Present at the RBC Capital Healthcare Conference on February 26, 2014
11/06/13
Summary ToggleLantheus Medical Imaging to Host Third Quarter 2013 Conference Call on November 13, 2013 at 3:00 p.m. Eastern Time Summary ToggleLantheus Medical Imaging to Host Third Quarter 2013 Conference Call on November 13, 2013 at 3:00 p.m. Eastern Time
10/29/13
Summary ToggleLantheus Releases Preliminary Results from Phase 3 Clinical Trial of Flurpiridaz F 18 for the Detection of Coronary Artery Disease Summary ToggleLantheus Releases Preliminary Results from Phase 3 Clinical Trial of Flurpiridaz F 18 for the Detection of Coronary Artery Disease
09/10/13
Summary ToggleLantheus Medical Imaging to Present at Imperial Capital Global Opportunities Conference on September 19, 2013 Summary ToggleLantheus Medical Imaging to Present at Imperial Capital Global Opportunities Conference on September 19, 2013
08/01/13
Summary ToggleLantheus Medical Imaging to Host Second Quarter 2013 Conference Call on August 8, 2013 at 4:00 p.m. Eastern Time Summary ToggleLantheus Medical Imaging to Host Second Quarter 2013 Conference Call on August 8, 2013 at 4:00 p.m. Eastern Time
07/11/13
Summary ToggleLantheus Medical Imaging Announces Chief Financial Officer Transition Summary ToggleLantheus Medical Imaging Announces Chief Financial Officer Transition
06/12/13
Summary ToggleLantheus Medical Imaging to Present at Wells Fargo Securities 2013 Healthcare Conference Summary ToggleLantheus Medical Imaging to Present at Wells Fargo Securities 2013 Healthcare Conference
05/29/13
Summary ToggleLantheus Medical Imaging to Present at Jefferies 2013 Global Healthcare Conference Summary ToggleLantheus Medical Imaging to Present at Jefferies 2013 Global Healthcare Conference
05/07/13
Summary ToggleLantheus Medical Imaging to Host First Quarter 2013 Conference Call on May 14, 2013 at 4:00 p.m. Eastern Time Summary ToggleLantheus Medical Imaging to Host First Quarter 2013 Conference Call on May 14, 2013 at 4:00 p.m. Eastern Time
05/01/13
Summary ToggleLantheus Medical Imaging to Proceed with Flurpiridaz F 18 Phase 3 Clinical Program Based on Interim Analysis of Data from First Phase 3 Study Summary ToggleLantheus Medical Imaging to Proceed with Flurpiridaz F 18 Phase 3 Clinical Program Based on Interim Analysis of Data from First Phase 3 Study
04/29/13
Summary ToggleLantheus Medical Imaging to Present Data on Novel PET Cardiac Imaging Agent Flurpiridaz F 18 at ICNC 11th Annual Meeting Summary ToggleLantheus Medical Imaging to Present Data on Novel PET Cardiac Imaging Agent Flurpiridaz F 18 at ICNC 11th Annual Meeting
04/15/13
Summary ToggleLantheus Medical Imaging Realigns Executive Leadership Team Summary ToggleLantheus Medical Imaging Realigns Executive Leadership Team
03/28/13
Summary ToggleLantheus Medical Imaging to Host Fourth Quarter 2012 Conference Call on April 2, 2013 at 4:00 p.m. Eastern Time Summary ToggleLantheus Medical Imaging to Host Fourth Quarter 2012 Conference Call on April 2, 2013 at 4:00 p.m. Eastern Time
03/21/13
Summary ToggleLantheus Medical Imaging Focuses on Growth, Takes Steps to Reduce Expenses Summary ToggleLantheus Medical Imaging Focuses on Growth, Takes Steps to Reduce Expenses
03/19/13
Summary ToggleLantheus Medical Imaging Announces Molybdenum-99 Supply Contract with Institute for Radioelements Summary ToggleLantheus Medical Imaging Announces Molybdenum-99 Supply Contract with Institute for Radioelements
03/06/13
Summary ToggleLantheus Medical Imaging Announces Appointment of Cesare Orlandi, M.D., as New Chief Medical Officer Summary ToggleLantheus Medical Imaging Announces Appointment of Cesare Orlandi, M.D., as New Chief Medical Officer
02/11/13
Summary ToggleLantheus Medical Imaging Announces FDA Approval of Jubilant HollisterStier Summary ToggleLantheus Medical Imaging Announces FDA Approval of Jubilant HollisterStier
01/24/13
Summary ToggleLantheus Medical Imaging Announces Appointment of Jeffrey A. Bailey as New Chief Executive Officer Summary ToggleLantheus Medical Imaging Announces Appointment of Jeffrey A. Bailey as New Chief Executive Officer
01/09/13
Summary ToggleLantheus Medical Imaging Introduces Low-Enriched Uranium (LEU) TechneLite® Generator Summary ToggleLantheus Medical Imaging Introduces Low-Enriched Uranium (LEU) TechneLite® Generator
01/03/13
Summary ToggleLantheus Medical Imaging and FUJIFILM RI Pharma Renew Long-Term License and Distribution Agreement for Cardiolite and Neurolite in Japan Summary ToggleLantheus Medical Imaging and FUJIFILM RI Pharma Renew Long-Term License and Distribution Agreement for Cardiolite and Neurolite in Japan
11/07/12
Summary ToggleLantheus Medical Imaging to Host Third Quarter 2012 Conference Call on November 13, 2012 at 4:00 p.m. Eastern Time Summary ToggleLantheus Medical Imaging to Host Third Quarter 2012 Conference Call on November 13, 2012 at 4:00 p.m. Eastern Time
10/31/12
Summary ToggleLantheus Medical Imaging Extends Contract with NTP Radioisotopes to Ensure Robust Supply of LEU-Produced Molybdenum-99 Summary ToggleLantheus Medical Imaging Extends Contract with NTP Radioisotopes to Ensure Robust Supply of LEU-Produced Molybdenum-99
10/22/12
Summary ToggleLantheus Medical Imaging and Nordion Extend Molybdenum-99 Supply Contract through 2015 Summary ToggleLantheus Medical Imaging and Nordion Extend Molybdenum-99 Supply Contract through 2015
09/13/12
Summary ToggleLantheus Medical Imaging to Present at Imperial Capital Global Opportunities Conference on September 20, 2012 Summary ToggleLantheus Medical Imaging to Present at Imperial Capital Global Opportunities Conference on September 20, 2012
09/10/12
Summary ToggleLantheus MI Holdings, Inc. Appoints Brian A. Markison to its Board of Directors Summary ToggleLantheus MI Holdings, Inc. Appoints Brian A. Markison to its Board of Directors
08/10/12
Summary ToggleLantheus Medical Imaging to Host Second Quarter 2012 Conference Call on August 16, 2012 at 4:00 p.m. Eastern Time Summary ToggleLantheus Medical Imaging to Host Second Quarter 2012 Conference Call on August 16, 2012 at 4:00 p.m. Eastern Time
07/18/12
Summary ToggleLantheus Medical Imaging Announces Appointment of Michael W. Heslop as Vice President, International Summary ToggleLantheus Medical Imaging Announces Appointment of Michael W. Heslop as Vice President, International
07/02/12
Summary ToggleCaRES Study Published in the Journal of the American Society of Echocardiography Further Demonstrates the Safety and Tolerability of Ultrasound Contrast Agent DEFINITY® in a Large and Diverse Patient Population Summary ToggleCaRES Study Published in the Journal of the American Society of Echocardiography Further Demonstrates the Safety and Tolerability of Ultrasound Contrast Agent DEFINITY® in a Large and Diverse Patient Population
06/19/12
Summary ToggleLantheus Selected to Receive $300,000 Massachusetts-Israel Innovation Partnership Grant Summary ToggleLantheus Selected to Receive $300,000 Massachusetts-Israel Innovation Partnership Grant
06/12/12
Summary ToggleLantheus Medical Imaging to Present at Wells Fargo Securities 2012 Healthcare Conference Summary ToggleLantheus Medical Imaging to Present at Wells Fargo Securities 2012 Healthcare Conference
05/31/12
Summary ToggleLantheus Medical Imaging to Present at Jefferies 2012 Global Healthcare Conference Summary ToggleLantheus Medical Imaging to Present at Jefferies 2012 Global Healthcare Conference
05/17/12
Summary ToggleLantheus Medical Imaging to Host First Quarter 2012 Conference Call on May 23, 2012 at 4:00 p.m. Eastern Time Summary ToggleLantheus Medical Imaging to Host First Quarter 2012 Conference Call on May 23, 2012 at 4:00 p.m. Eastern Time
05/17/12
Summary ToggleLantheus Appoints New Member to its Board of Directors Summary ToggleLantheus Appoints New Member to its Board of Directors
05/09/12
Summary ToggleLantheus Medical Imaging Announces Manufacturing and Supply Agreements with Jubilant HollisterStier LLC for Cardiolite® and Neurolite® Summary ToggleLantheus Medical Imaging Announces Manufacturing and Supply Agreements with Jubilant HollisterStier LLC for Cardiolite® and Neurolite®
05/03/12
Summary ToggleLantheus Medical Imaging Announces Appointment of Alexander E. Kuta, Ph.D., as Vice President, Global Regulatory Affairs and Nigel Williams as Vice President, Quality Summary ToggleLantheus Medical Imaging Announces Appointment of Alexander E. Kuta, Ph.D., as Vice President, Global Regulatory Affairs and Nigel Williams as Vice President, Quality
03/29/12
Summary ToggleLantheus Medical Imaging to Host Fourth Quarter/2011 Conference Call on April 5, 2012 at 4:00 p.m. Eastern Time Summary ToggleLantheus Medical Imaging to Host Fourth Quarter/2011 Conference Call on April 5, 2012 at 4:00 p.m. Eastern Time
02/23/12
Summary ToggleLantheus Medical Imaging Announces Strategic Relationship with Beijing Double-Crane Pharmaceuticals for the Distribution and Supply of DEFINITY® in China Summary ToggleLantheus Medical Imaging Announces Strategic Relationship with Beijing Double-Crane Pharmaceuticals for the Distribution and Supply of DEFINITY® in China
02/21/12
Summary ToggleLantheus Medical Imaging to Present at Upcoming Investor Conferences Summary ToggleLantheus Medical Imaging to Present at Upcoming Investor Conferences
01/04/12
Summary ToggleLantheus Medical Imaging Announces Chief Financial Officer Robert Gaffey to Retire Summary ToggleLantheus Medical Imaging Announces Chief Financial Officer Robert Gaffey to Retire
11/14/11
Summary ToggleLantheus Medical Imaging to Host Third Quarter 2011 Conference Call Summary ToggleLantheus Medical Imaging to Host Third Quarter 2011 Conference Call
10/28/11
Summary ToggleLantheus Medical Imaging Announces Labeling Changes for DEFINITY® Summary ToggleLantheus Medical Imaging Announces Labeling Changes for DEFINITY®
10/24/11
Summary ToggleLantheus Medical Imaging Awarded Three-Year Supplier Agreements with the Premier Healthcare Alliance for Ultrasound Contrast Agent DEFINITY® andMagnetic Resonance Angiography Imaging Agent ABLAVAR® Summary ToggleLantheus Medical Imaging Awarded Three-Year Supplier Agreements with the Premier Healthcare Alliance for Ultrasound Contrast Agent DEFINITY® andMagnetic Resonance Angiography Imaging Agent ABLAVAR®
10/24/11
Summary ToggleLantheus Medical Imaging Awarded Three-Year Supplier Agreement with the Premier Healthcare Alliance for Radiopharmaceutical Products Summary ToggleLantheus Medical Imaging Awarded Three-Year Supplier Agreement with the Premier Healthcare Alliance for Radiopharmaceutical Products
09/28/11
Summary ToggleLantheus Medical Imaging Announces Promotion Of Cyrille Villeneuve To Chief Commercial Officer And Dana Washburn, M.D. To Chief Medical Officer Summary ToggleLantheus Medical Imaging Announces Promotion Of Cyrille Villeneuve To Chief Commercial Officer And Dana Washburn, M.D. To Chief Medical Officer
08/16/11
Summary ToggleLantheus Medical Imaging to Host Second Quarter 2011 Conference Call Summary ToggleLantheus Medical Imaging to Host Second Quarter 2011 Conference Call
07/27/11
Summary ToggleLantheus Medical Imaging Announces Management Change Summary ToggleLantheus Medical Imaging Announces Management Change
07/26/11
Summary ToggleLantheus Medical Imaging Announces Promotion Of Jeffrey Young To Vice President, Finance Summary ToggleLantheus Medical Imaging Announces Promotion Of Jeffrey Young To Vice President, Finance
06/30/11
Summary ToggleLantheus Medical Imaging Initiates Phase 3 Clinical Trial of Flurpiridaz F 18 for the Detection of Coronary Artery Disease Summary ToggleLantheus Medical Imaging Initiates Phase 3 Clinical Trial of Flurpiridaz F 18 for the Detection of Coronary Artery Disease
06/02/11
Summary ToggleLantheus Medical Imaging to Present at Jefferies 2011 Global Healthcare Conference Summary ToggleLantheus Medical Imaging to Present at Jefferies 2011 Global Healthcare Conference
06/01/11
Summary ToggleLantheus Medical Imaging to Present Data on Novel PET Cardiac and Heart Failure Imaging Agents at SNM 58th Annual Meeting Summary ToggleLantheus Medical Imaging to Present Data on Novel PET Cardiac and Heart Failure Imaging Agents at SNM 58th Annual Meeting
05/18/11
Summary ToggleLantheus Medical Imaging to Host First Quarter 2011 Conference Call Summary ToggleLantheus Medical Imaging to Host First Quarter 2011 Conference Call
05/17/11
Summary ToggleLantheus Medical Imaging Presents Phase 2 Study Results of PET Myocardial Perfusion Summary ToggleLantheus Medical Imaging Presents Phase 2 Study Results of PET Myocardial Perfusion
05/13/11
Summary ToggleLantheus Medical Imaging to Present Phase 2 Data of PET Myocardial Perfusion Imaging with Flurpiridaz F 18 at the International Conference of Non-Invasive Cardiovascular Imaging Summary ToggleLantheus Medical Imaging to Present Phase 2 Data of PET Myocardial Perfusion Imaging with Flurpiridaz F 18 at the International Conference of Non-Invasive Cardiovascular Imaging
05/03/11
Summary ToggleLantheus Medical Imaging Presents Promising Results of Latest Safety Studies Summary ToggleLantheus Medical Imaging Presents Promising Results of Latest Safety Studies
04/11/11
Summary ToggleLantheus Medical Imaging Commences Exchange Offer Summary ToggleLantheus Medical Imaging Commences Exchange Offer
03/16/11
Summary ToggleLantheus Medical Imaging Announces Proposed Private Offering of $150 Million of Senior Unsecured Notes Summary ToggleLantheus Medical Imaging Announces Proposed Private Offering of $150 Million of Senior Unsecured Notes
03/16/11
Summary ToggleLantheus Medical Imaging Announces Expiration of Consent Solicitation and Receipt of Requisite Consents Summary ToggleLantheus Medical Imaging Announces Expiration of Consent Solicitation and Receipt of Requisite Consents
03/11/11
Summary ToggleLantheus Medical Imaging Receives Special Protocol Assessment Approval from FDA for Phase 3 Trial of Flurpiridaz F-18 for the Diagnosis of Coronary Artery Disease Summary ToggleLantheus Medical Imaging Receives Special Protocol Assessment Approval from FDA for Phase 3 Trial of Flurpiridaz F-18 for the Diagnosis of Coronary Artery Disease
03/04/11
Summary ToggleLantheus Medical Imaging Commences Consent Solicitation Summary ToggleLantheus Medical Imaging Commences Consent Solicitation
02/03/11
Summary ToggleLantheus Medical Imaging Announces Completion of Exchange Offer for its 9.750% Senior Notes Due 2017 Summary ToggleLantheus Medical Imaging Announces Completion of Exchange Offer for its 9.750% Senior Notes Due 2017
01/21/11
Summary ToggleLantheus Medical Imaging Announces New National Contract with Novation for ABLAVAR® and DEFINITY® Summary ToggleLantheus Medical Imaging Announces New National Contract with Novation for ABLAVAR® and DEFINITY®
01/18/11
Summary ToggleLantheus Medical Imaging Announces Promotion Of Robert Gaffey To Chief Financial Officer Summary ToggleLantheus Medical Imaging Announces Promotion Of Robert Gaffey To Chief Financial Officer
01/05/11
Summary ToggleLantheus Medical Imaging Extends Molybdenum-99 Contract with Nordion Summary ToggleLantheus Medical Imaging Extends Molybdenum-99 Contract with Nordion
12/31/10
Summary ToggleLantheus Medical Imaging Commences Exchange Offer Summary ToggleLantheus Medical Imaging Commences Exchange Offer
12/13/10
Summary ToggleLantheus Medical Imaging Announces FDA Accepts for Review DEFINITY® Supplemental New Drug Application for Use in Stress Echocardiography Summary ToggleLantheus Medical Imaging Announces FDA Accepts for Review DEFINITY® Supplemental New Drug Application for Use in Stress Echocardiography
12/06/10
Summary ToggleLantheus Medical Imaging Announces First Commercial Production of TechneLite® Generators from Low-Enriched Uranium-Produced Molybdenum-99 Summary ToggleLantheus Medical Imaging Announces First Commercial Production of TechneLite® Generators from Low-Enriched Uranium-Produced Molybdenum-99
10/14/10
Summary ToggleLantheus Medical Imaging, Inc. Launches ABLAVAR® in Canada Summary ToggleLantheus Medical Imaging, Inc. Launches ABLAVAR® in Canada
09/20/10
Summary ToggleLantheus Medical Imaging, Inc. to Present Clinical Data on Investigational Cardiac PET Imaging Agents at American Society of Nuclear Cardiology Summary ToggleLantheus Medical Imaging, Inc. to Present Clinical Data on Investigational Cardiac PET Imaging Agents at American Society of Nuclear Cardiology
09/10/10
Summary ToggleLantheus Medical Imaging, Inc. Commends Safety Labeling Changes Announced by U.S. Food and Drug Administration for Gadolinium-Based Contrast Agents Summary ToggleLantheus Medical Imaging, Inc. Commends Safety Labeling Changes Announced by U.S. Food and Drug Administration for Gadolinium-Based Contrast Agents
07/15/10
Summary ToggleLantheus Medical Imaging, Inc. Launches DEFINITY® Ultrasound Contrast Imaging Agent in India Summary ToggleLantheus Medical Imaging, Inc. Launches DEFINITY® Ultrasound Contrast Imaging Agent in India
07/12/10
Summary ToggleLantheus Medical Imaging, Inc. Purchases Balance of Worldwide Rights for MRA Imaging Agent ABLAVAR® (Gadofosveset Trisodium) Summary ToggleLantheus Medical Imaging, Inc. Purchases Balance of Worldwide Rights for MRA Imaging Agent ABLAVAR® (Gadofosveset Trisodium)
07/08/10
Summary ToggleLantheus Medical Imaging, Inc. Announces Agreement with MDS Nordion to Secure Additional Supply of Molybdenum-99 (Mo-99), a Key Medical Isotope Summary ToggleLantheus Medical Imaging, Inc. Announces Agreement with MDS Nordion to Secure Additional Supply of Molybdenum-99 (Mo-99), a Key Medical Isotope
06/14/10
Summary ToggleLantheus Medical Imaging, Inc. Presents Phase 4 Safety Data on DEFINITY® at American Society of Echocardiography Annual Meeting Summary ToggleLantheus Medical Imaging, Inc. Presents Phase 4 Safety Data on DEFINITY® at American Society of Echocardiography Annual Meeting
06/09/10
Summary ToggleLantheus Medical Imaging, Inc. Recognized as Top-Performing Supplier by Premier Purchasing Partners, L.P. Summary ToggleLantheus Medical Imaging, Inc. Recognized as Top-Performing Supplier by Premier Purchasing Partners, L.P.
06/09/10
Summary ToggleLantheus Medical Imaging, Inc. Presents Preliminary Data on Novel PET Myocardial Perfusion Imaging Agent Protocol at SNM Annual Meeting Summary ToggleLantheus Medical Imaging, Inc. Presents Preliminary Data on Novel PET Myocardial Perfusion Imaging Agent Protocol at SNM Annual Meeting
06/08/10
Summary ToggleLantheus Medical Imaging, Inc. Presents Phase 1 Data Highlighting Safety, Dosimetry and Tolerability of Novel PET Heart Failure Imaging Agent at SNM Annual Meeting Summary ToggleLantheus Medical Imaging, Inc. Presents Phase 1 Data Highlighting Safety, Dosimetry and Tolerability of Novel PET Heart Failure Imaging Agent at SNM Annual Meeting
06/07/10
Summary ToggleLantheus Medical Imaging, Inc. Presents Preliminary Data Comparing Novel Cardiac PET Imaging Agent With SPECT at SNM Annual Meeting Summary ToggleLantheus Medical Imaging, Inc. Presents Preliminary Data Comparing Novel Cardiac PET Imaging Agent With SPECT at SNM Annual Meeting
06/03/10
Summary ToggleLantheus Medical Imaging, Inc. to Present at Jefferies 2010 Global Life Sciences Conference Summary ToggleLantheus Medical Imaging, Inc. to Present at Jefferies 2010 Global Life Sciences Conference
06/03/10
Summary ToggleLantheus Medical Imaging, Inc. Announces Magnetic Resonance Angiography (MRA) Contract Award for ABLAVAR® With Amerinet, Inc. Summary ToggleLantheus Medical Imaging, Inc. Announces Magnetic Resonance Angiography (MRA) Contract Award for ABLAVAR® With Amerinet, Inc.
05/21/10
Summary ToggleLantheus Medical Imaging, Inc. Announces Increased Access to Medical Isotope Molybdenum-99 From Czech Nuclear Research Institute Summary ToggleLantheus Medical Imaging, Inc. Announces Increased Access to Medical Isotope Molybdenum-99 From Czech Nuclear Research Institute
05/19/10
Summary ToggleLantheus Medical Imaging, Inc. to Present Data on Cardiovascular PET Imaging Pipeline Candidates at SNM Annual Meeting Summary ToggleLantheus Medical Imaging, Inc. to Present Data on Cardiovascular PET Imaging Pipeline Candidates at SNM Annual Meeting
04/22/10
Summary ToggleLantheus Medical Imaging, Inc. Announces Appointment of Dana S. Washburn, M.D., as Vice President, Clinical Development and Medical Affairs Summary ToggleLantheus Medical Imaging, Inc. Announces Appointment of Dana S. Washburn, M.D., as Vice President, Clinical Development and Medical Affairs
03/16/10
Summary ToggleLantheus Medical Imaging, Inc. Presents Preliminary Phase 2 Data With Flurpiridaz F 18 (BMS747158), a Novel PET Cardiac Imaging Agent, at the American College Of Cardiology 59th Annual Scientific Session Summary ToggleLantheus Medical Imaging, Inc. Presents Preliminary Phase 2 Data With Flurpiridaz F 18 (BMS747158), a Novel PET Cardiac Imaging Agent, at the American College Of Cardiology 59th Annual Scientific Session
03/09/10
Summary ToggleLantheus Medical Imaging, Inc. to Present New Data on Novel PET Cardiac and Heart Failure Imaging Agents at the American College of Cardiology 59th Annual Scientific Session in Atlanta Summary ToggleLantheus Medical Imaging, Inc. to Present New Data on Novel PET Cardiac and Heart Failure Imaging Agents at the American College of Cardiology 59th Annual Scientific Session in Atlanta
02/17/10
Summary ToggleLantheus Medical Imaging, Inc. Announces Appointment of Robert A. Spurr as Summary ToggleLantheus Medical Imaging, Inc. Announces Appointment of Robert A. Spurr as
01/20/10
Summary ToggleLantheus Medical Imaging, Inc. Launches ABLAVAR™ (Gadofosveset Trisodium), a New Diagnostic Magnetic Resonance Angiography Agent Summary ToggleLantheus Medical Imaging, Inc. Launches ABLAVAR™ (Gadofosveset Trisodium), a New Diagnostic Magnetic Resonance Angiography Agent
10/08/09
Summary ToggleData Featuring Gadofosveset Trisodium, the First and Only MRA Blood Pool Agent Approved in the U.S. Presented at MRA-Club 09: 21st Annual International Conference on Magnetic Resonance Angiography Summary ToggleData Featuring Gadofosveset Trisodium, the First and Only MRA Blood Pool Agent Approved in the U.S. Presented at MRA-Club 09: 21st Annual International Conference on Magnetic Resonance Angiography
09/17/09
Summary ToggleLantheus Medical Imaging, Inc. Initiates Phase 1 Study Evaluating Safety and Dosimetry of Novel Heart Failure Imaging Agent Summary ToggleLantheus Medical Imaging, Inc. Initiates Phase 1 Study Evaluating Safety and Dosimetry of Novel Heart Failure Imaging Agent
08/14/09
Summary ToggleLantheus Continues to Address Industry Shortage of Mo-99 Resulting from Prolonged NRU Reactor Shutdown Summary ToggleLantheus Continues to Address Industry Shortage of Mo-99 Resulting from Prolonged NRU Reactor Shutdown
07/09/09
Summary ToggleLantheus Medical Imaging, Inc. Announces FDA and Health Canada Approval of Australian Nuclear Science and Technology Organisation (ANSTO)-Supplied Key Medical Isotope to Manufacture Technelite® Generator Summary ToggleLantheus Medical Imaging, Inc. Announces FDA and Health Canada Approval of Australian Nuclear Science and Technology Organisation (ANSTO)-Supplied Key Medical Isotope to Manufacture Technelite® Generator
06/14/09
Summary ToggleScientists Who Made Significant Contribution to Discovery of Lantheus Medical Imaging’s Cardiolite® Honored with Prestigious Nuclear Medicine Award at SNM Annual Meeting Summary ToggleScientists Who Made Significant Contribution to Discovery of Lantheus Medical Imaging’s Cardiolite® Honored with Prestigious Nuclear Medicine Award at SNM Annual Meeting
06/13/09
Summary ToggleLantheus Medical Imaging, Inc. to Receive LEU-Derived MO-99 from Australian Nuclear Science and Technology Organisation (ANSTO) and Becomes First to Supply U.S. Market Summary ToggleLantheus Medical Imaging, Inc. to Receive LEU-Derived MO-99 from Australian Nuclear Science and Technology Organisation (ANSTO) and Becomes First to Supply U.S. Market
06/12/09
Summary ToggleBARI 2D Study Presented at American Diabetes Association Scientific Sessions Underscores Utility of Spect Myocardial Perfusion Imaging in Identifying Cardiovascular Risk and Evaluating Treatment Outcomes for Patients with Type 2 Diabetes Summary ToggleBARI 2D Study Presented at American Diabetes Association Scientific Sessions Underscores Utility of Spect Myocardial Perfusion Imaging in Identifying Cardiovascular Risk and Evaluating Treatment Outcomes for Patients with Type 2 Diabetes
06/04/09
Summary ToggleSpect MPI with Cardiolite® Used in BARI 2D Study to Evaluate Type 2 Diabetes and Coronary Artery Disease Treatment Strategies Summary ToggleSpect MPI with Cardiolite® Used in BARI 2D Study to Evaluate Type 2 Diabetes and Coronary Artery Disease Treatment Strategies
05/28/09
Summary ToggleLantheus Medical Imaging, Inc. Completes Enrollment of Cares Registry to Further Evaluate Definity® in Patients with Suboptimal Echocardiograms Summary ToggleLantheus Medical Imaging, Inc. Completes Enrollment of Cares Registry to Further Evaluate Definity® in Patients with Suboptimal Echocardiograms
05/20/09
Summary ToggleLantheus Medical imaging, Inc. Takes Proactive Steps to Mitigate Impact of Global Molybdenum-99 Supply Crisis on Operations Summary ToggleLantheus Medical imaging, Inc. Takes Proactive Steps to Mitigate Impact of Global Molybdenum-99 Supply Crisis on Operations
04/07/09
Summary ToggleLantheus Medical Imaging, Inc. Acquires U.S., Canadian and Australian Rights TO MS-325 (formerly marketed as VASOVIST®, gadofosveset trisodium, by Bayer Schering Pharma) from EPIX Pharmaceuticals Summary ToggleLantheus Medical Imaging, Inc. Acquires U.S., Canadian and Australian Rights TO MS-325 (formerly marketed as VASOVIST®, gadofosveset trisodium, by Bayer Schering Pharma) from EPIX Pharmaceuticals
03/30/09
Summary ToggleLantheus Medical Imaging Presents Phase I Study Results of Novel Pet Myocardial Perfusion Imaging Tracer aAt ACC Summary ToggleLantheus Medical Imaging Presents Phase I Study Results of Novel Pet Myocardial Perfusion Imaging Tracer aAt ACC
03/29/09
Summary ToggleNew Lantheus Study Finds Significant Survival Benefit for Critically Ill Patients Undergoing Contrast-Enhanced Echocardiography Summary ToggleNew Lantheus Study Finds Significant Survival Benefit for Critically Ill Patients Undergoing Contrast-Enhanced Echocardiography
03/25/09
Summary ToggleLantheus Medical Imaging to Present New Cardiac Imaging Data at The American College of Cardiology 58th Annual Scientific Sessions in Orlando Summary ToggleLantheus Medical Imaging to Present New Cardiac Imaging Data at The American College of Cardiology 58th Annual Scientific Sessions in Orlando
02/24/09
Summary ToggleNew Study Published in Journal of the American College of Cardiology Finds Utilization of Contrast Echocardiography with Definity® Improves Patient Diagnosis and Management Summary ToggleNew Study Published in Journal of the American College of Cardiology Finds Utilization of Contrast Echocardiography with Definity® Improves Patient Diagnosis and Management
01/27/09
Summary ToggleNew Study Published in the Journal of Nuclear Cardiology Explores the Utility of Spect Myocardial Perfusion Imaging with Cardiolite® in Patients with New-Onset of Heart Failure Summary ToggleNew Study Published in the Journal of Nuclear Cardiology Explores the Utility of Spect Myocardial Perfusion Imaging with Cardiolite® in Patients with New-Onset of Heart Failure
12/15/08
Summary ToggleNew Study Published in The American Journal Of Cardiology Finds Survival Benefit Among Hospitalized Patients Undergoing Definity®-Enhanced Echocardiography Summary ToggleNew Study Published in The American Journal Of Cardiology Finds Survival Benefit Among Hospitalized Patients Undergoing Definity®-Enhanced Echocardiography
11/05/08
Summary ToggleLantheus Medical Imaging Welcomes New ASE Consensus Statement on Clinical Applications of Contrast Echocardiography Summary ToggleLantheus Medical Imaging Welcomes New ASE Consensus Statement on Clinical Applications of Contrast Echocardiography
11/04/08
Summary ToggleLantheus Medical Imaging Announces Strategic Hires to Core Business Areas Summary ToggleLantheus Medical Imaging Announces Strategic Hires to Core Business Areas
10/24/08
Summary ToggleLantheus Medical Imaging Awarded Second Consecutive Sole-Source Supplier Contract from Premier for Definity® Summary ToggleLantheus Medical Imaging Awarded Second Consecutive Sole-Source Supplier Contract from Premier for Definity®
09/05/08
Summary ToggleNew Data on Breast Imaging Using Cardiolite® to be Presented at ASCO Breast Cancer Symposium Summary ToggleNew Data on Breast Imaging Using Cardiolite® to be Presented at ASCO Breast Cancer Symposium
06/17/08
Summary ToggleLantheus Medical Imaging Presents Phase I Study Results of Novel Pet Myocardial Perfusion Imaging Tracer Summary ToggleLantheus Medical Imaging Presents Phase I Study Results of Novel Pet Myocardial Perfusion Imaging Tracer
06/12/08
Summary ToggleLantheus Medical Imaging Receives Performance Award from Premier Purchasing Partners, L.P. Summary ToggleLantheus Medical Imaging Receives Performance Award from Premier Purchasing Partners, L.P.
05/13/08
Summary ToggleLantheus Medical Imaging Updates Definity® Label to Modify Benefit/Risk Assessment of the Product Summary ToggleLantheus Medical Imaging Updates Definity® Label to Modify Benefit/Risk Assessment of the Product
05/06/08
Summary ToggleLantheus Medical Imaging Initiates Cares Registry to Further Evaluate Definity® in Patients with Suboptimal Echocardiograms Summary ToggleLantheus Medical Imaging Initiates Cares Registry to Further Evaluate Definity® in Patients with Suboptimal Echocardiograms
03/18/08
Summary ToggleWorldwide Leader in Diagnostic Medicine is Launched as Lantheus Medical Imaging Summary ToggleWorldwide Leader in Diagnostic Medicine is Launched as Lantheus Medical Imaging